This site requires JavaScript to be enabled to work properly. Please modify your settings or use a different browser to continue

       

You are now leaving GSK’s website

This link will take you to a non-GSK website. GSK does not recommend, endorse or accept liability for sites controlled by third-parties.

Continue

Go back

Thank you for updating your preferences. If you have opted out from communication from noreply@gsk.com. All changes will be implemented within a 10 day time frame. We hope to see you again sometime soon

Update communication preferences from noreply@gsk.com

We hope you enjoy receiving email communications from GSK.  To change the type of email communications you receive from (noreply@gsk.com), or to stop all email communications from (noreply@gsk.com), please update your preferences below.

Please note you may continue to receive emails from other GSK email accounts. Please opt out of those communications through the opt out link at the bottom of the email.    
If you receive email directly from your local GSK representative, please inform your local GSK representative of any changes to your email preferences.

Please select Email/SMS as the communication channel

You have chosen Email/SMS as the communication channel without specifying particular preferences. This will subscribe you to all possible options. If you wish to change your preferences, deselect any topics that you do not wish to receive information and click again on Update

Unsubscribe from all

If you wish to opt out from all email communications from (noreply@gsk.com) please scroll down. Please note you may continue to receive emails from your local GSK representative. If you wish to change this please inform your local GSK representative.

By clicking on update, you are accepting our terms of use and privacy policy, you indicate that you wish to receive information from GlaxoSmithKline Saudi Arabia. Your information will be validated to comply with our legal requirements which may cause a slight delay in receiving your first email.

GlaxoSmithKline Saudi Arabia will use your information to administer your email subscription, for statistical analysis and to keep you up to date with developments and news relating to this website (where appropriate). We may need to share your details with our agents for these purposes.

Update

Thanks. You have opted out from receiving mails from GSK.

PM-AE-DV-WCNT-220001 Date of Preparation: January 2022